SCHEMBL8424775

SCHEMBL8424775

CCCCCCCCCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CC(=O)O)C(=O)NC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP2 P08253 14/20 0.59
▸ MMP8 P22894 12/20 0.59
▸ MMP9 P14780 10/20 0.59
▸ CCKBR P32239 1/20 0.56
▸ MMP1 P03956 10/20 0.55
▸ MMP3 P08254 3/20 0.53
▸ MMP14 P50281 4/20 0.52
▸ MMP13 P45452 2/20 0.51
▸ ADAM10 O14672 1/20 0.50
▸ ADAM12 O43184 1/20 0.50
▸ ADAMTS4 O75173 1/20 0.50
▸ MMP7 P09237 1/20 0.50
▸ MMP12 P39900 1/20 0.50
▸ MMP15 P51511 1/20 0.50
▸ MMP16 P51512 1/20 0.50
▸ ADAM17 P78536 1/20 0.50
▸ ADAM9 Q13443 1/20 0.50
▸ MMP26 Q9NRE1 1/20 0.50
▸ MMP17 Q9ULZ9 1/20 0.50
▸ ADAMTS5 Q9UNA0 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8242009 0.94 CCKBR (0.56) MMP2MMP8MMP9CCKBRMMP1
SCHEMBL8363652 0.92 CCKBR (0.61) MMP2MMP8MMP9CCKBRMMP1
SCHEMBL8426512 0.88 MMP2 (0.63) MMP2MMP8MMP9CCKBRMMP1
SCHEMBL8363817 0.87 MMP2 (0.62) MMP2MMP8MMP9CCKBRMMP1
SCHEMBL8426483 0.87 MMP2 (0.62) MMP2MMP8MMP9CCKBRMMP1
SCHEMBL31016495 0.87 CCKBR (0.57) MMP2MMP8CCKBRMMP1MMP7
SCHEMBL31016498 0.87 CCKBR (0.57) MMP2MMP8CCKBRMMP1MMP7
SCHEMBL31016490 0.87 CCKBR (0.57) MMP2MMP8CCKBRMMP1MMP7
SCHEMBL31016497 0.87 CCKBR (0.57) MMP2MMP8CCKBRMMP1MMP7
SCHEMBL8426510 0.86 MMP2 (0.62) MMP2MMP8MMP9CCKBRMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080119395-A1 Novel Depsipeptides and Process for Preparing Same CUBIST PHARMACEUTICALS, INC. 2008-05-22 — — US disclosed
US-20060194714-A1 Novel depsipeptides and process for preparing same CUBIST PHARMACEUTICALS, INC. 2006-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194714-A1 Novel depsipeptides and process for preparing same VIP, DNPEP, PREP MMP2 1509/4885MMP8 1241/4885MMP9 2211/4885
US-20080119395-A1 Novel Depsipeptides and Process for Preparing Same VIP, DNPEP, PREP MMP2 1509/4885MMP8 1241/4885MMP9 2211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback